 Incidence new primary cancers adjuvant tamoxifen therapy radiotherapy early breast cancer incidence new primary cancers postmenopausal patients surgical treatment primary breast cancer patients low risk recurrence treatment High-risk patients groups first group postoperative radiotherapy second group radiotherapy tamoxifen dose mg weeks median observation time years comparison number new cancers general population number new cancers groups due high number cancers contralateral breast colorectal cancers high-risk groups cumulative risk nonlymphatic leukemia patients postoperative radiotherapy Cancer incidence high-risk tamoxifen-treated group relative high-risk group tamoxifen significant protective effect tamoxifen opposite breast rate ratio breast cancer tendency risk endometrial cancer rate ratio confidence interval careful follow-up women tamoxifen necessary potential cancer-suppressive cancer-promoting effects drug